Endothelial cell-targeted pVEGF165 polyplex plays a pivotal role in inhibiting intimal thickening after vascular injury

References

• GandhiNSTekadeRKChouguleMBNanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advancesJ Control Release2014194C23825625204288
   PubMed Web of Science ®Google Scholar
• YinRXYangDZWuJZNanoparticle drug-and gene-eluting stents for the prevention and treatment of coronary restenosisTheranostics20144217520024465275
   PubMed Web of Science ®Google Scholar
• WonYWBullDAKimSWFunctional polymers of gene delivery for treatment of myocardial infarctJ Control Release201419511011925076177
   PubMed Web of Science ®Google Scholar
• MandelRJBurgerCSnyderROViral vectors for in vivo gene transfer in Parkinson’s disease: properties and clinical grade productionExp Neurol20082091587117916354
   PubMed Web of Science ®Google Scholar
• RotheMSchambachABiascoLSafety of gene therapy: new insights to a puzzling caseCurr Gene Ther201414642943625245088
   PubMed Web of Science ®Google Scholar
• PutnamDGentryCAPackDWLangerRPolymer-based gene delivery with low cytotoxicity by a unique balance of side-chain terminiProc Natl Acad Sci U S A20019831200120511158617
   PubMed Web of Science ®Google Scholar
• ParkTGJeongJHKimSWCurrent status of polymeric gene delivery systemsAdv Drug Deliv Rev200658446748616781003
   PubMed Web of Science ®Google Scholar
• TieraMJShiQWinnikFMFernandesJCPolycation-based gene therapy: current knowledge and new perspectivesCurr Gene Ther201111428830621453278
   PubMed Web of Science ®Google Scholar
• YinHKanastyRLEltoukhyAAVegasAJDorkinJRAndersonDGNon-viral vectors for gene-based therapyNat Rev Genet201415854155525022906
   PubMed Web of Science ®Google Scholar
• KircheisRSchullerSBrunnerSPolycation-based DNA complexes for tumor-targeted gene delivery in vivoJ Gene Med19991211112010738575
   PubMed Web of Science ®Google Scholar
• OgrisMBrunnerSSchullerSKircheisRWagnerEPEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene deliveryGene Ther19996459560510476219
   PubMed Web of Science ®Google Scholar
• LaiTCBaeYYoshidaTKataokaKKwonGSpH-sensitive multi-PEGylated block copolymer as a bioresponsive pDNA delivery vectorPharm Res201027112260227320300803
   PubMed Web of Science ®Google Scholar
• MishraSWebsterPDavisMEPEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particlesEur J Cell Biol20048339711115202568
   PubMed Web of Science ®Google Scholar
• MerkelOMLibrizziDPfestroffAStability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by fluorescence fluctuation spectroscopy and single photon emission computed tomography (SPECT) imagingJ Control Release2009138214815919463870
   PubMed Web of Science ®Google Scholar
• HyodoMSakuraiYAkitaHHarashimaH“Programmed packaging” for gene deliveryJ Control Release201419331632324780263
   PubMed Web of Science ®Google Scholar
• ChengZAlZAHuiJZMuzykantovVRTsourkasAMultifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesScience2012338610990391023161990
   PubMed Web of Science ®Google Scholar
• BartlettDWSuHHildebrandtIJWeberWADavisMEImpact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingProc Natl Acad Sci U S A200710439155491555417875985
   PubMed Web of Science ®Google Scholar
• KirpotinDBDrummondDCShaoYAntibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsCancer Res200666136732674016818648
   PubMed Web of Science ®Google Scholar
• McNeeleyKMAnnapragadaABellamkondaRVDecreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of gliomaNanotechnology20071838385101
   Web of Science ®Google Scholar
• van der MeelRVehmeijerLJKokRJStormGvan GaalEVLigand-targeted particulate nanomedicines undergoing clinical evaluation: current statusAdv Drug Deliv Rev201365101284129824018362
   PubMed Web of Science ®Google Scholar
• ZhangYSatterleeAHuangLIn vivo gene delivery by nonviral vectors: overcoming hurdles?Mol Ther20122071298130422525514
   PubMed Web of Science ®Google Scholar
• VicentiniFTBorgheti-CardosoLNDepieriLVDelivery systems and local administration routes for therapeutic siRNAPharm Res201330491593123344907
   PubMed Web of Science ®Google Scholar
• HoebenALanduytBHighleyMSWildiersHVan OosteromATDe BruijnEAVascular endothelial growth factor and angiogenesisPharmacol Rev200456454958015602010
   PubMed Web of Science ®Google Scholar
• HutterRCarrickFEValdiviezoCVascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injuryCirculation2004110162430243515477421
   PubMed Web of Science ®Google Scholar
• ThipparaboinaRKhanWDombAJEluting combination drugs from stentsInt J Pharm2013454141023850234
   PubMedGoogle Scholar
• RutanenJTurunenAMTeittinenMGene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanismGene Ther2005121298098715759018
   PubMed Web of Science ®Google Scholar
• KishoreRLosordoDWGene therapy for restenosis: biological solution to a biological problemJ Mol Cell Cardiol200742346146817222423
   PubMed Web of Science ®Google Scholar
• GalvagniFOrlandiniMOlivieroSRole of the AP-1 transcription factor FOSL1 in endothelial cells adhesion and migrationCell Adh Migr20137540841124084233
   PubMed Web of Science ®Google Scholar
• LiuSRadiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalencyBioconjug Chem200920122199221319719118
   PubMed Web of Science ®Google Scholar
• TateishiUOkaTInoueTRadiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracersCurr Med Chem201219203301330922664242
   PubMed Web of Science ®Google Scholar
• CaoDQinLHuangHFengMPanSChenJTransfection activity and the mechanism of pDNA-complexes based on the hybrid of low-generation PAMAM and branched PEI-1.8kMol Biosyst20139123175318624126459
   PubMedGoogle Scholar
• HuangHCaoDQinLDilution-stable PAMAM G1-grafted polyrotaxane supermolecules deliver gene into cells through a caveolae-dependent pathwayMol Pharm20141172323233324957192
   PubMedGoogle Scholar
• PanditaDSantosJLRodriguesJPegoAPGranjaPLTomasHGene delivery into mesenchymal stem cells: a biomimetic approach using RGD nanoclusters based on poly(amidoamine) dendrimersBiomacromolecules201112247248121210673
   PubMed Web of Science ®Google Scholar
• StraussBHChisholmRJKeeleyFWGotliebAILoganRAArmstrongPWExtracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosisCirc Res19947546506587923611
   PubMed Web of Science ®Google Scholar
• KawaiJAndoKTojoAEndogenous adrenomedullin protects against vascular response to injury in miceCirculation200410991147115314769703
   PubMed Web of Science ®Google Scholar
• HuntMACurrieMJRobinsonBADachsGUOptimizing transfection of primary human umbilical vein endothelial cells using commercially available chemical transfection reagentsJ Biomol Tech2010212667220592869
   PubMedGoogle Scholar
• LazarousDFShouMStiberJAAdenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardialangiogenesisCardiovasc Res199944229430210690306
   PubMed Web of Science ®Google Scholar
• TsaiWCLiYHHuangYYLinCCChaoTHChenJHPlasma vascular endothelial growth factor as a marker for early vascular damage in hypertensionClin Sci (Lond)20051091394315740459
   PubMed Web of Science ®Google Scholar
• MontetXFunovicsMMontet-AbouKWeisslederRJosephsonLMultivalent effects of RGD peptides obtained by nanoparticle displayJ Med Chem200649206087609317004722
   PubMed Web of Science ®Google Scholar
• WaiteCLRothCMBinding and transport of PAMAM-RGD in a tumor spheroid model: the effect of RGD targeting ligand densityBiotechnol Bioeng2011108122999300821755497
   PubMed Web of Science ®Google Scholar
• HunterACMolecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicityAdv Drug Deliv Rev200658141523153117079050
   PubMed Web of Science ®Google Scholar
• NgQKSuttonMKSoonsawadPXingLChengHSeguraTEngineering clustered ligand binding into nonviral vectors: alphavbeta3 targeting as an exampleMol Ther200917582883619240693
   PubMed Web of Science ®Google Scholar